2021
DOI: 10.7861/clinmed.2020-0370
|View full text |Cite
|
Sign up to set email alerts
|

Hydrogen treatment: a novel option in liver diseases

Abstract: Hydrogen therapy is a very promising treatment against several diseases due to its mild attributes, high affinity and inherent biosafety. However, there is little elaboration about current hydrogen treatment in liver diseases. This article introduces the administration of hydrogen and mechanisms of hydrogen therapy in vivo, including modulating reactive oxygen species, apoptosis and autophagy, and inflammation, affecting mitochondria, as well as protein transporters. The major focus is clinical hydrogen use an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
4
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 41 publications
0
4
0
2
Order By: Relevance
“…Overall, these results indicate that G2-SUISO represents a simple and novel therapeutic strategy for NASH and NAFLD. Previous studies also showed that H 2 therapy is a very promising treatment of liver diseases and the rational use of it has already solved many problems clinically 47 . However, the current clinical delivery method of H 2 is not very convenient, and G2-SUISO can be made into capsules to solve this problem and facilitate H 2 administration.…”
Section: Discussionmentioning
confidence: 99%
“…Overall, these results indicate that G2-SUISO represents a simple and novel therapeutic strategy for NASH and NAFLD. Previous studies also showed that H 2 therapy is a very promising treatment of liver diseases and the rational use of it has already solved many problems clinically 47 . However, the current clinical delivery method of H 2 is not very convenient, and G2-SUISO can be made into capsules to solve this problem and facilitate H 2 administration.…”
Section: Discussionmentioning
confidence: 99%
“…It has been reported that the balance between H 2 -producing and consuming bacteria is essential for normal H 2 cycling in the organs of mammals in order to prevent immune inflammatory reactions induced by pathogen infection. 24 According to a previous study, hydrogenase might instead utilize H 2 and release energy to boost the production of pathogenic-related proteins and enzymes that induced inflammation and necrosis that directly caused the liver lesions in mice. 25 We hypothesized that accumulation of H. hepaticus hydrogenase-oxidized H 2 to enhance virulence by producing high-efficiency solute uptake systems.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, the mutant infection did not lead more severe hepatitis and liver fibrosis compared to WT H. hepaticus , suggesting that hydrogenase promoted H. hepaticus growth and virulence during infection. It has been reported that the balance between H 2 ‐producing and consuming bacteria is essential for normal H 2 cycling in the organs of mammals in order to prevent immune inflammatory reactions induced by pathogen infection 24 . According to a previous study, hydrogenase might instead utilize H 2 and release energy to boost the production of pathogenic‐related proteins and enzymes that induced inflammation and necrosis that directly caused the liver lesions in mice 25 .…”
Section: Discussionmentioning
confidence: 99%
“…c The timedependent ROC curves of 1-, 3-, and 5-year overall survival probabilities for HCC patients was predicted by nomogram (HBV) or C (HCV) virus, often result in liver cirrhosis, which is a critical risk factor for the progression of HCC [22][23][24][25]. And hepatitis infection is associated with not only liver disease but also thalassemia [26,27]. Chronic liver injury is associated with the abnormal regulation of hepatocytes growth, leading to dysplastic and regenerative nodules and tumorigenesis of HCC [25].…”
Section: Discussionmentioning
confidence: 99%